SFGP
EW icon

Stonebridge Financial Group (Pennsylvania)’s Edwards Lifesciences EW Stock Holding History

Stonebridge Financial Group (Pennsylvania)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Buy
2,719
+1
+0% +$84 0.02% 246
2026
Q1 		$218K Buy
2,718
+20
+0.7% +$1.65K 0.02% 243
2025
Q4 		$230K Buy
2,698
+29
+1% +$2.38K 0.02% 229
2025
Q3 		$208K Buy
2,669
+4
+0.2% +$313 0.02% 234
2025
Q2 		$208K Buy
2,665
+12
+0.5% +$895 0.02% 230
2025
Q1 		$192K Buy
2,653
+13
+0.5% +$930 0.02% 226
2024
Q4 		$195K Buy
+2,640
New +$185K 0.02% 225

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Stonebridge Financial Group (Pennsylvania)'s EW Position: Q2 2026 in Review

Stonebridge Financial Group (Pennsylvania) increased its Edwards Lifesciences (EW) stake by 0.04% in Q2 2026, buying an estimated $84 and bringing the position to 2,719 shares worth $246K. The position accounts for 0.02% of the portfolio, ranked #246.

Stonebridge Financial Group (Pennsylvania) first reported a position in EW in Q4 2024 and has held it in 7 quarters since. 1,096 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Stonebridge Financial Group (Pennsylvania) held 2,719 shares of Edwards Lifesciences worth $246K as of Q2 2026.
  • Stonebridge Financial Group (Pennsylvania) bought 1 Edwards Lifesciences share in Q2 2026, an estimated $84.
  • Edwards Lifesciences made up 0.02% of Stonebridge Financial Group (Pennsylvania)'s portfolio in Q2 2026, its #246 holding.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • 1,096 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2026, filed 6 Jul 2026.